Thalidomide as an emerging immunotherapeutic agent

Immunology Today

Volumn 20, Issue 12, 1999, Pages 538-540

  Marriott, J Blake ^a   Muller, George ^b   Dalgleish, Angus G ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; BIRTH DEFECT; CANCER PATIENT; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG INDICATION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW;

EID: 0033485968     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(99)01531-5     Document Type: Short Survey

References (52)

1. Fullerton P.M., Kremer M. Br. Med. J. 2:1961;855-858.
2. McBride W.G. Lancet. ii:1961;1358.
3. Mellen G.W., Katzenstein M. New Engl. J. Med. 267:1962;1184-1193.
4. Taussig H. JAMA. 180:1962;1106-1114.
5. Zeldis J.B., Williams B.A., Thomas S.D., Elsayed M.E. Clin. Ther. 21:1999;319-330.
6. Sheskin J. Lepr. Rev. 36:1965;163-178.
7. Iyer G.C.S., Languillon J., Ramanujam K.et al. Bull. WHO. 45:1971;719-732.
8. Sampaio E.P., Kaplan G., Miranda A.et al. J. Infect. Dis. 168:1993;408-414.
9. Vogelsang G.B., Santos G.W., Colvin O.M., Chen T. Lancet. i:1988;827.
10. Vogelsang G.B., Farmer E.R., Hess A.D.et al. New Engl. J. Med. 326:1992;1055-1058.
11. Schuler U., Ehninger G. Drug Safety. 12:1995;364-369.
12. Ehninger G., Eger K., Stuhler A., Schuler U. Bone Marrow Transplant. 12:1993;S26-S28.
13. Klausner J.D., Makonkawkeyoon S., Akarasewi P.et al. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 11:1996;247-257.
14. Hamuryudan V., Mat C., Saip S.et al. Ann. Intern. Med. 128:1998;443-450.
15. Wettstein A.R., Meagher A.P. Lancet. 350:1997;1445-1446.
16. Youle M., Furthing C., Connolly M.et al. Br. Med. J. 298:1989;432.
17. Jacobson J.M., Greenspan J.S., Spritzler J.et al. New Engl. J. Med. 336:1991;1487-1493.
18. Alexander L.N., Wilcox C.M. AIDS Res. Hum. Retroviruses. 13:1997;301-304.
19. Anderson J.M., Greenspan J.S., Spritzler J.et al. New Engl. J. Med. 336:1997;1487-1493.
20. Sharpstone D., Rowbottom A., Nelson M., Gazzard B. AIDS. 9:1995;658-659.
21. Reyes-Terán G., Sierra-Madero J.G., Martinez del Cerro V.et al. AIDS. 10:1996;1501-1507.
22. Fife K., Howard M.R., Gracie F., Phillips R.H., Bower M. Int. J. STD AIDS. 9:1998;751-755.
23. Makonkawkeyoon S., Limson-Pobre R.N., Moreira A.L., Schauf V., Kaplan G. Proc. Natl. Acad. Sci. U. S. A. 90:1993;5974-5978.
24. Marriott J.B., Cookson S., Carlin E.et al. AIDS Res. Hum. Retroviruses. 13:1997;1625-1631.
25. Sampaio E.P., Sarno E.N., Galilly R., Cohn Z.A., Kaplan G. J. Exp. Med. 173:1991;699-703.
26. Moreira A.L., Sampaio E.P., Zmudzinas A.et al. J. Exp. Med. 177:1993;1675-1680.
27. Shannon E.J., Ejigu M., Haile-Mariam H.S., Berhan T.Y., Tasesse G. Lepr. Rev. 63:1992;5-11.
28. Marriott J.B., Westby M., Dalgleish A.G. Drug Discovery Today. 2:1997;273-282.
29. Eigler A., Sinha B., Hartmann G., Endres S. Immunol. Today. 18:1997;487-492.
30. McHugh S.M., Rifkin I.R., Deighton J.et al. Clin. Exp. Immunol. 99:1995;160-167.
31. Moller D.R., Wysocka M., Greenlee B.et al. J. Immunol. 159:1997;5157-5161.
32. Hauschild A., Kroeger H., Mitchison N. Clin. Exp. Immunol. 108:1997;428-431.
33. Oliver S.J., Cheng T.P., Banquerigo M.L., Brahn E. J. Rheumatol. 25:1998;964-969.
34. Haslett P.A.J., Corral L.G., Albert M., Kaplan G. J. Exp. Med. 187:1998;1885-1892.
35. Azuma A., Miyachi J., Shibata Y., Hashimoto Y., Iwasaki S. Biol. Pharm. Bull. 19:1996;1001-1003.
36. Miyachi H., Azuma A., Hioki E.et al. Biochem. Biophys. Res. Commun. 226:1996;439-444.
37. Singhal, S., Mehta, J., Eddlemon, P. et al. (1998) Blood 92 (Suppl. 1, Abstr. 1306).
38. D'Amato R.J., Loughnan M., Flynn E., Folkman J. Proc. Natl. Acad. Sci. U. S. A. 91:1994;4082-4085.
39. Kruse F.E., Joussen A.M., Rohrschneider K., Becker M.D., Volcker H.E. Graefe's Arch. Clin. Exp. Ophthalmol. 236:1998;461-466.
40. Pollard M. Cancer Lett. 101:1996;21-24.
41. Ruegg C., Yilmaz A., Bieler G.et al. Nat. Med. 4:1998;408-414.
42. Sooville, C.D. (1996) Arthritis Rheum. 39, S281 (Abstr. 1523).
43. Lee, S., Klausner, J., Oliver, S. et al. (1996) Arthritis Rheum. 39, S282 (Abstr. 1524).
44. Huizinga T.W., Dijkmans B.A., van der Velde E.A.et al. Ann. Rheum. Dis. 55:1996;833-836.
45. Chen T.L., Vogelsang G.B., Petty B.G.et al. Drug Metab. Dispos. 17:1989;402-405.
46. Wnendt S., Zwingenberger K. Nature. 385:1997;303.
47. Eriksson T., Bjorkman S., Roth B., Fyge A., Hoglund P. Chirality. 7:1995;44-52.
48. Corral L.G., Muller G.W., Moreira A.L.et al. Mol. Med. 2:1996;506-515.
49. Muller G.W., Corral L.G., Shire M.G.et al. J. Med. Chem. 39:1996;3238-3240.
50. Muller G.W., Shire M.G., Wong L.M.et al. Bioorg. Med. Chem. Lett. 8:1998;2669-2674.
51. Marriott J.B., Westby M., Cookson S.et al. J. Immunol. 161:1998;4236-4243.
52. Shimazawa R., Miyachi H., Takayama H.et al. Biol. Pharm. Bull. 22:1999;224-226.